COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details Narrative) - USD ($)		12 Months Ended
	Nov. 06, 2020	Jun. 30, 2024	Jun. 30, 2023	Oct. 06, 2023
Available for sale securities amortized costs		$ 3,964,000	$ 2,714,000
Investments included net unrealized gain (loss)		1,800,000	(219,000)
Gross unrealized gains		2,100,000	67,000
Gross unrealized losses		261,000	286,000
Marketable equity securities		987,000	1,134,000
Cash				$ 1,250,000
Common stock shares				1,828,551
Exercise unrealized loss investment				$ 38,000
Fair value of the Monogram common stock		3,200,000
Depreciation expenses		1,038,000	727,000
Retired assets		85,000	760,000
Amortization expense		28,000	$ 37,000
Future amortization expense, year one		30,000
Future amortization expense, year two		$ 30,000
Franklin [Member]
Payment to acquired property plant equipment	$ 6,500,000
Payment of property plant equipment	1,300,000
Bank financed	$ 5,200,000
Monogram Orthopaedics Inc [Member]
Exercisable warrants			1,823,058
Estimated fair value of warrant			$ 6,160,000